Opioid and opiate immunoregulatory processes

Critical Reviews in Immunology

Volumn 16, Issue 2, 1996, Pages 109-144

  Stefano, George B ^a,f,g   Scharrer, Berta ^b   Smith, Eric M ^c   Hughes Jr , Thomas K ^d   Magazine, Harold I ^e   Bilfinger, Thomas V ^f   Hartman, Alan R ^f   Fricchione, Gregory L ^g   Liu, Yu ^a   Makman, Maynard H ^b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

^e CITY UNIVERSITY OF NEW YORK   (United States)

^f STONY BROOK UNIVERSITY   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

human immunocytes; invertebrates; morphine; opiate receptors; opioid peptides

Indexed keywords

CYTOKINE; ENKEPHALIN; MORPHINE; NEUROPEPTIDE; NITRIC OXIDE; OPIATE PEPTIDE; OPIATE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTINOCICEPTION; CELL COMMUNICATION; CELL MIGRATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE ADHERENCE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFLAMMATION; NEUROENDOCRINE SYSTEM; NONHUMAN; PARASITISM; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SUBSTANCE ABUSE;

ANIMALS; CELL COMMUNICATION; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MODELS, IMMUNOLOGICAL; NARCOTICS; NERVOUS SYSTEM PHYSIOLOGY; OPIOID PEPTIDES; RECEPTORS, OPIOID;

EID: 9544233532     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (258)

1. Blalock, J. E., A molecular basis for bidirectional communication between the immune and neuroendocrine systems, Physiol. Rev., 69, 1, 1989.
2. Stefano, G. B. and Scharrer, B., Endogenous morphine and related opiates, a new class of chemical messengers, Adv. Neuroimmunol., 4, 57, 1994.
3. Stefano, G. B., Cadet, P., and Scharrer, B., Stimulatory effects of opioid neuropeptides on locomotory activity and conformational changes in invertebrate and human immunocytes: evidence for a subtype of delta receptor, Proc. Natl. Acad. Sci. U.S.A., 86, 6307, 1989.
4. Stefano, G. B., Leung, M. K., Zhao, X., and Scharrer, B., Evidence for the involvement of opioid neuropeptides in the adherence and migration of immunocompetent invertebrate hemocytes, Proc. Natl. Acad. Sci. U.S.A., 86, 626, 1989.
5. Heagy, W., Laurance, M., Cohen, E., and Finberg, R., Neurohormones regulate T-cell function, J. Exp. Med., 171, 1625, 1990.
6. Shipp, M. A., Stefano, G. B., D'Adamio, L., Switzer, S. N., Howard, F. D., Sinisterra, J. I., Scharrer, B., and Reinherz, E., Downregulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11, Nature, 347, 394, 1990.
7. Brown, S. L., Tokuda, S., Saland, L. C., and VanEpps, D. E., Enkephalins and Endorphins: Stress and the Immune System, Plenum Press, New York, 1986.
8. Shipp, M. A., Stefano, G. B., Switzer, S. N., Griffin, J. D., and Reinherz, E., CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation, Blood, 78, 1834, 1991.
9. Finn, J. P., Steele, L. M., Barney, P. E., and Eckroat, L. R., Opioid involvement in the stimulation of conformational changes of immunocytes from the freshwater bivalve mollusc Proptera alata as revealed by light and scanning electron microscopy, Prog. Neuroendocr. Immunol., 4, 180, 1991.
10. VanEpps, D. E., Durant, D. A., and Potter, J. W., Migration of human helper/inducor T cells in respnse to supernatants from Con-A-stimulated suppressor/ cytotoxic T cells, J. Immunol., 131, 697, 1983.
11. Ruff, M. R. and Pert, C. B., Enkephalins and Endorphins: Stress and the Immune System, Plenum Press, New York, 1986.
12. Saland, L. C., VanEpps, D. E., Ortiz, E., and Samora, A., Acute injections of opiate peptides into the rat cerebral ventricle: a macrophage-like cellular response, Brain Res. Bull., 10, 523, 1983.
13. 125I-β-endorphin in human polymorphonuclear leukocytes, Cell. Biol. Int. Rep., 10, 429, 1986.
14. Stefano, G. B., Kushnerik, V., Rodriquez, M., and Bilfinger, T. V., Inhibitory effect of morphine on granulocyte stimulation by tumor necrosis factor and substance p, Int. J. Immunopharm., 16, 329, 1994.
15. Stefano, G. B., Leung, M. K., Bilfinger, T. V., and Scharrer, B., Effect of prolonged exposure to morphine on responsiveness of human and invertebrate immunocytes to stimulatory molecules, J. Neuroimmunol., 63, 175, 1995.
16. VanEpps, D. E. and Saland, L. C., Beta-endorphin and met-enkephalin stimulate peripheral blood mononuclear cell chemotaxis, J. Immunol., 132, 3046, 1984.
17. Simpkins, C. O., Dickey, C. A., and Fink, M. P., Human neutrophil migration is enhanced by endorphin, Life Sci., 34, 2251, 1984.
18. Casale, T. B., Bowman, S., and Kaliner, M., Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and nonopiate receptor participation, J. Allergy Clin. Immunol., 73, 775, 1984.
19. Hughes, T. K. J., Smith, E. M., Cadet, P., Sinisterra, J. I., Leung, M. K., Shipp, M. A., Scharrer B., and Stefano, G. B., Interaction of immunoactive monokines (IL-1 and TNF) in the bivalve mollusc Mytilus edulis, Proc. Natl. Acad. Sci. U.S.A., 87, 4426, 1990.
20. Brown, S. L. and VanEpps, D. E., Suppression of T-lymphocyte chemotactic factor production by the opioid peptides beta-endorphin and met-enkephalin, J. Immunol., 134, 3384, 1985.
21. Stefano, G. B., Melchiorri, P., Negri, L., Hughes, T. K. J., and Scharrer, B., (D-Ala2)-Deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells, Proc. Natl. Acad. Sci. U.S.A., 89, 9316, 1992.
22. Linner, K. M., Quist, H. E., and Sharp, B. M., Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation, J. Immunol., 154, 5049, 1995.
23. Liu, Y. and Stefano, G. B., HIV Gp120 inhibits human and invertebrate immunocyte phagocytosis, Chinese J. Immunol., 1995.
24. Milligan, C. E., Webster, L., Piros, E. T., Evans, C. J., Cunningham, T. J., and Levitt, P., Induction of opioid receptor-mediated macrophage chemotactic activity after neonatal brain injury, J. Immunol , 154, 6571, 1995.
25. Falke, N. E. and Fischer E. G., Cell shape of polymorphonuclear leukocytes is influenced by opioids, Immunobiology, 169, 532, 1985.
26. Fischer, E. G. and Falke, N. E., Enkephalins and Endorphins: Stress and the Immune System, Plenum Press, New York, 1986.
27. Stanley, T. H., Hill, G. E., Portas, M. R., Hogan, N. A., and Hill, H. R., Neutrophil chemotaxis during and after general anesthesia and operation, Anesth. Analg., 55, 668, 1976.
28. Zucker-Franklin, D., Elsbach, P., and Simon, E. J., The effect of morphine analog levorphanol on phagocytosing leukocytes, Lab. Invest., 25, 415, 1971.
29. Gyires, K., Budavarit, I., Furst, S., and Molnar, I., Morphine inhibits the carrageemam-induced oedema and the chemoluminescence of leucocytes stimulated by zymosan, J. Pharm. Pharmacol., 37, 100, 1985.
30. Stefano, G. B., Digenis, A., Spector, S., Leung, M. K., Bilfinger, T. V., Makman, M. H., Scharrer, B., and Abumrad, N. N., Opiatelike substances in an invertebrate, a novel opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression, Proc. Natl. Acad, Sci. U.S.A., 90, 11099, 1993.
31. Miller, G. C., Murgo, A. J., and Plotnikoff, N. P., Enkephalins-enhancement of active T-cell rosettes from normal volunteers, Clin. Immunol. Immunopathol., 31, 132, 1984.
32. Wybran, J., Appelboom, T., Famaey, J. P., and Govaerts, A., Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes, J. Immunol., 123, 1068, 1979.
33. Miller, G. C., Murgo, A. J., and Plotnikoff, N. P., Enkephalins-enhancement of active T-cell rosettes from lymphoma patients, Clin. Immunol. Immunopathol., 26, 446, 1983.
34. McCain, H. W., Lamster, I. B., Bozzone, J. M., and Grbic, J. T., Beta-endorphin modulates human immune activity via non-opiate receptor mechanisms, Life Sci., 31, 1619, 1982.
35. Gilman, S. C., Schwartz, J. M., Milner, R. J., Bloom, F. E., and Feldman, J. D., Beta-endorphin enhances lymphocyte proliferative responses, Proc. Natl. Acad. Sci. U.S.A., 79, 4226, 1982.
36. Plotnikoff, N. P. and Miller, G. C., Enkephalins as immunomodulators, Int. J. Immunopharm., 5, 437, 1983.
37. Johnson, H. M., Smith, E. M., Torres, B. A., and Blalock, J. E., Regulation of the in vitro antibody response by neuroendocrine hormones, Proc. Natl. Acad. Sci. U.S.A., 79, 4171, 1982.
38. Bocchini, G., Bonnano, G., and Canevari, A., Influence of morphine and naloxone on human peripheral blood T-lymphocytes, Drug. Alcohol. Depend., 11, 233, 1983.
39. Mathews, P. M., Froelich, C. J., Sibbitt, W. L. J., and Bankhurst, A. D., Enhancement of natural cytotoxicity by beta-endorphin, J. Immunol., 130, 1658, 1983.
40. Faith, R. E., Liang, H. J., Murgo, A. J., and Plotnikoff, N. P., Neuroimmunomodulation with enkephalins: enhancement of human natural killer (NK) cell activity in vitro, Clin. Immunol., 31, 412, 1984.
41. Kay, M., Allen, J., and Morley, J. E., Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity, Life Sci., 35, 53, 1984.
42. 14C-serotonin release, Agents Actions, 13, 21, 1982.
43. Fjellner, B. and Hagermark, O., Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK 33 824,beta-endorphin and morphine, Arch. Dermatol. Res., 274, 29, 1982.
44. Marie, D. and Jankovic, B. D., Suppression of anaphylactic shock by enkephalins, Ann. N.Y. Acad. Sci., 450, 684, 1988.
45. Jankovic, B. D. and Maric, D., Neuropeptides and Immunoregulation, Springer-Verlag, Berlin, 1994.
46. Heagy, W., Finberg, R., Teng, E., McAllen, K., and Sharp, B., Opiate receptors and signalling in lymphocytes, Adv. Exp. Med. Biol., 1995.
47. Ottavianni, E., Franchini, A., Sonetti, D., and Stefano, G. B., Antagonizing effect of morphine on the mobility and phagocytic activity of invertebrate immunocytes, Eur. J. Pharmacol., 276, 35, 1995.
48. Chiesa, R., Silva, W. I., and Renaud F. L., Pharmacological characterization of an opioid receptor in the ciliate Tetrahymena, J. Eukary Microbiol., 800, 1993.
49. Luza, J., Effect of morphine on phagocytic activity of the polymorphonuclears and monocytes, Acta. Univ. Palacki. Olomuc. Fac. Med., 134, 47, 1992.
50. Szabo, I., Rojavin, M., Bussiere, J. L., Eisenstein, T. K., Adler, M. W., and Rogers, T. J., Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids, J. Pharmacol. Exp. Ther , 267, 703, 1993.
51. Rojavin, M., Szabo, I., Bussiere, J. L., Rogers, T. J., Adler, M. W., and Eisenstein, T. K., Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sci., 53, 997, 1993.
52. Liu, Y., Blackcourn, D. J., Chuang, L. F., Killam, K. F. J., and Chuang, R. Y., Effects of in vivo and in vitro administration of morphine sulfate on rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis, J. Pharmacol. Exp. Ther., 263, 533, 1992.
53. Casellas, A. M., Guardiola, H., and Renaud, F. L., Inhibition by opioids of phagocytosis in peritoneal macrophages, Neuropeptides, 18, 35, 1991.
54. Zurawski, G., Benedik, M., Kamb, B. J., Abrams, J. S., Zurawski, S. M., and Lee, F. D., Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis, Science, 232, 772, 1986.
55. Smith, E. M. and Blalock, J. E., Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon, Proc. Natl. Acad. Sci. U.S.A., 78, 7530, 1981.
56. Lolait, S. J., Lim, A. T. W., Toh, B. H., and Fimder, J. W., Immunoreactive endorphin in a subpopulation of mouse spleen macrophages, J. Clin. Invest., 73, 277, 1984.
57. Lolait, S. J., Clements, J. A., Markwick, A. J., Cheng, C., McNally, M., Smith, A. I., and Funder, J. W., Proopiomelanocortin messenger ribonucleic acid and posttranslational processing of endorphin in spleen macrophages, J. Clin. Invest., 77, 1776, 1986.
58. Leung, M. K. and Stefano, G. B., Comparative neurobiology of opioids in invertebrates with special attention to senescent alterations, Prog. Neurobiol., 28, 131, 1987.
59. Clement-Jones, V., Lowry, P. J., Rees, J. H., and Besser, G. M., Development of a specific extracted radioimmunoassay for methionine enkephalin in human plasma and cerebrospinal fluid, J. Endocrinol., 86, 231, 1980.
60. Kimura, T., Ota, K., Matsui, K., Iitake, K., Shoji, M., Inoue, M., Yoshinaga, K., and Share, L., The presence of methionine-enkephalin in plasma and urine in normal human subjects and various patients, Endocrinol. Jpn., 32, 514, 1985.
61. Hughes, T. K. and Chin, R., Neuropeptides and Immunoregulation, Springer-Verlag, Berlin, 1994.
62. Scharrer, B. and Stefano, G. B., Neuropeptides and Immunoregulation, Springer-Verlag, Berlin, 1994.
63. Stefano, G. B., Leung, M. K., Szucs, A., Rozsa, K. S., Smith, E. M., Hughes, T. K. J., Ottavianni, E., Franceschi, C., Duvaux-Miret, O., Capron, A., and Scharrer, B., Autoimmunoregulation and the importance of opioid peptides, Ann. N.Y. Acad. Sci., 712, 92, 1993.
64. Menzies, R. A., Patel, R., Hall, N. R., O'Grady, M. P., and Rier, S. E., Human recombinant interferon alpha inhibits naloxone binding to rat brain membranes, Life Sci., 50, PL227, 1992.
65. Saphier, D., Roerig, S. C., Ito, C., Vlasak, W. R., Farrar, G. E., Broyles, J. E., and Welch, J. E., Inhibition of neural and neuroendocrine activity by alpha-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat, Brain Behav. Immun., 8, 37, 1994.
66. Saphier, D., Neuroendocrine effects of interferon-alpha in the rat, Adv. Exp. Med. Biol., 373, 209, 1995.
67. Nakashima, T., Murakami, T., Murai, Y., Hori, T., Miyata, S., and Kiyohara, T., Naloxone suppresses the rising phase of fever induced by interferon-alpha, Brain Res. Bull., 37, 61, 1995.
68. Take, S., Mori, T., Katafuchi, T., and Hori, T., Central interferon-alpha inhibits natural killer cytotoxicity through sympathetic innervation, Am. J. Physiol., 265, R453, 1993.
69. Katafuchi, T., Take, S., and Hori, T., Roles of sympathetic nervous system in the suppression of cytotoxicity of splenic natural killer cells in the rat, J. Physiol., 465, 343, 1993.
70. Ho, B. T., Huo, Y. Y., Lu, J. G., Tansey, L. W., and Levin, V. A., Opioid-dopaminergic mechanisms in the potentiation of d-amphetamine discrimination by interferon-alpha, Pharmacol. Biochem. Behav., 42, 57, 1992.
71. DiStefano, A. and Paulesu, L., Inhibitory effect of melatonin on production of IFN gamma or TNF alpha in peripheral blood mononuclear cells of some blood donors, J. Pineal. Res., 17, 164, 1994.
72. Van den Bergh, P., Dobber, R., Ramlal, S., Rozing, J., and Nagelkerken, L., Role of opioid peptides in the regulation of cytokine production by murine CD4+ T cells, Cell. Immunol., 154, 109, 1994.
73. Van den Bergh, P., Rozing, J., and Nagelkerken, L., Identification of distinct sites of beta-endorphin that stimulate lymphokine production by murine CD4+ T cells, Lymphokine Cytokine Res., 13, 63, 1994.
74. Low, K. G., Allen, R. G., and Meiner, M. H., Differential regulation of proenkephalin expression in astrocytes by cytokines, Endocrinology, 131, 1908, 1992.
75. Marotti, T., Burek, B., Rabatic, S., Balog, T., and Hrsak, I., Modulation of lipopolysaccharide-induced production of cytokines by methionine enkephalin, Immunol. Lett., 40, 43, 1994.
76. Belkowski, S. M., Alicea, C., Portoghese, P. S., Adler, M. W., and Rogers, T. J., Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50,488H, J. Pharmacol. Exp. Ther., 273, 1491, 1995.
77. Jean, A. P., Maloteaux, J. M., and Laduron, P. M., IL-1 beta-like Freund's adjuvant enhances axonal transport of opiate receptors in sensory neurons, Neurosci. Lett., 177, 75, 1994.
78. Sacerdote, P., Blanchi, M., Manfredi, B., and Panerai, A. E., Intracerebroventricular interleukin-1 alpha increases immunocyte beta-endorphin concentrations in the rat: involvement of corticotropin-releasing hormone, catecholamines, and serotonin, Endocrinology, 135, 1346, 1994.
79. Schafer, M., Carter, L., and Stein, C., Interleukin-1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue, Proc. Natl. Acad. Sci. U.S.A., 91, 4219, 1994.
80. Bonavera, J. J., Kalra, S. P., and Kalra, P. S., Mode of action of interleukin-1 in suppression of pituitary LH release in castrated male rats, Brain Res., 612, 1, 1993.
81. Bonavera, J. J., Kalra, S. P., and Kalra, P. S., Evidence that luteinizing hormone suppression in response to inhibitory neuropeptides. beta-endorphin, interleukin-1beta, and neuropeptide-K, may involve excitatory amino acids, Endocrinology, 133, 178, 1993.
82. Stefano, G. B. and Bilflnger, T. V., Human neutrophil and macrophage chemokinesis induced by cardiopulmonary bypass: loss of DAME and IL-1 chemotaxis, J. Neuroimmunol., 47, 189, 1993.
83. Stefano, G. B., Smith, E. M., Cadet, P., and Hughes, T. K. J., HIV GP120 alteration of DAMA and IL-1a induced chemotaxic responses in human and invertebrate immunocytes, J. Neuroimmunol., 43, 177, 1993.
84. Roy, S., Ge, B. L., Ramakrishnan, S., Lee, N. M., and Loh, H. H., [3H]-morphine binding is enhanced by IL-1 stimulated thymocyte proliferation, FEBS. Lett., 287, 93, 1991.
85. Poole, S., Bristow, A. F., Lorenzetti, B. B., Das, R. E., Smith, T. W., and Ferreira, S. H., Peripheral analgesic activities of peptides related to alpha-melanocyte stimulating hormone and interleukin-1 beta 193-195, Br. J. Pharmacol., 106, 489, 1992.
86. Bianchi, M., Sacerdote, P., Ricciardi-Castagnoli, P., Mantegazza, P., and Panerai, A. E., Central effects of tumor necrosis factor alpha and interleukin-1 alpha on nociceptive thresholds and spontaneous locomotor activity, Neurosci. Lett., 148, 76, 1992.
87. Negro, A., Tavella, A., Facci, L., Callegaro, L., and Skaper, S. D., Interleukin-1 beta regulates proenkephalin gene expression in astrocytes cultured from rat cortex, GLIA, 6, 206, 1992.
88. Stefano, G. B., Smith, E. M., and Hughes, T. K. J., Opioid induction of immunoreactive interleukin-1 in Mylilus edulis and human immunocytes: an interleukin-1-like substance in invertebrate neural tissue, J. Neuroimmunol., 32, 29, 1991.
89. Lissoni, P., Barni, S., Tancini, G., Fossati, V., and Frigerio, F., Pineal-opioid system interactions in the control of immunoinflammatory responses, Ann. N.Y. Acad. Sci., 741, 191, 1994.
90. Ho, B. T., Lu, J. G., Huo, Y. Y., Fan, S. H., Meyers, C. A., Tansey, L. W., Payne, R., and Levin, V. A., Neurochemical basis of interleukin 2-modified discrimination behavior, Cytokine, 6, 365, 1994.
91. Martin-Kleiner, I. and Gabrilovac, J., Naloxone modulates NK cell activity of human peripheral blood lymphocytes like an opioid agonist, Immunopharmacol. Immunotoxicol., 15, 179, 1993.
92. Lapchak, P. A. and Araujo, D. M., Interleukin-2 regulates monoamine and opioid peptide release from the hypothalamus, Neuroreport, 4, 303, 1993.
93. Czlonkowski, A., Stein, C., and Herz, A., Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines, Eur. J. Pharmacol., 242, 229, 1993.
94. Xin, L. and Blatteis, C. M., Hypothalamic neuronal responses to interleukin-6 in tissue slices: effects of indomethacin and naloxone. Brain Res. Bull., 29, 27, 1992.
95. Chao, C. C., Gekker, G., Sheng, W. S., Hu, S., Tsang, M., and Peterson, P. K., Priming effect of morphine on the production of tumor necrosis factor-α by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression, J. Exp. Pharmacol. Ther., 269, 198, 1994.
96. Panerai, A. E., Radulovic, J., Monastra, G., Manfredi, B., Locatelli, L., and Sacerdote, P., Beta-endorphin concentrations in brain areas and peritoneal macrophages in rats susceptible and resistant to experimental allergic encephalomyelitis: a possible relationship between tumor necrosis factor alpha and opioids in the disease, J. Immunol., 51, 169, 1994.
97. Chao, C. C., Molitor, T. W., Close, K., Hu, S., and Peterson, P. K., Morphine inhibits the release of tumor necrosis factor in human peripheral blood mononuclear cell cultures, Int. J. Immunopharm., 15, 447, 1993.
98. Chao, C. C., Hu, S., Molitor, T. W., Zhou, Y., Murtaugh, M. P., Tsang, M., and Peterson, P. K., Morphine potentiates transforming growth factor-B release from human peripheral blood mononuclear cell cultures, J. Pharmacol. Exp. Ther., 262, 19, 1992.
99. Lysle, D. T., Coussons, M. E., Watts, V. J., Bennett, E. H., and Dykstra, L. A., Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone, J. Pharmacol. Exp. Ther., 265, 1071, 1993.
100. Yeager, M. P., Colacchio, T. A., Yu, C. T., Hildebrandt, L., Howell, A. L., Weiss, J., and Guyre, P. M., Morphine inhibits spontaneous and cytokine-enchanced natural killer cell cytotoxicity in volunteers, Anesthesiology, 83, 500, 1995.
101. Jessopt, J. J. and Taplits, M. S., Effect of high doses of morphine on Con-A induced lymphokine production in vitro, Immunopharmacology, 22, 175, 1991.
102. Carr, D. J. J., DeCosta, B., Kim, C. H., Jacobson, A. E., Guarcello, V., Rice, K. C., and Blalock, J. E., Opioid receptors on cells of the immune system: evidence for d- and k-classes, J. Endocrinol., 122, 161, 1989.
103. Roy, S., Ge, B. L., Loh, H. H., and Lee, N. M., Characterization of [3H]-morphine binding to interleukin-1 activated thymocytes, J. Pharmacol. Exp. Ther., 263, 451, 1992.
104. Garza, H. H. J., Prakash, O., and Carr, D. J. J., Immunologic characterization of TAT72-transgenic mice: effects of morphine on cell-mediated immunity, Int. J. Immunopharm., 16, 1061, 1994.
105. Makman, M. H., Bilfinger, T. V., and Stefano, G. B., Human granulocytes contain an opiate receptor mediating inhibition of cytokine-induced activation and chemotaxis, J. Immunol., 154, 1323, 1995.
106. Chao, C. C., Molitor, T. W., Gekker, G., Murtaugh, M. P., and Peterson, P. K., Cocaine-mediated suppression of superoxide production by human peripheral blood mononuclear cells, J. Pharmacol. Exp. Ther., 256, 255, 1991.
107. Chiappelli, F., Frost, P., Manfrini, E., Lee, P., Pham, L., Garcia, C., Daley, S., Kung, M., and Villanueva, P., Cocaine blunts human CD4+ cell activation, Immunopharmacology, 28, 233, 1994.
108. Kavelaars, A., Ballieux, R. E., and Heijnen, C. J., Two different signalling pathways for the induction of immunoreactive beta-endorphin secretion by human peripheral blood mononuclear cells, Endocrinology, 128, 765, 1991.
109. Van den Bergh, P., Rozing, J., and Nagelkerken, L., Two opposing modes of action of beta-endorphin on lymphocyte function, Immunology, 72, 537, 1991.
110. Tosk, J. M., Grim, J. R., Kinback, K. M., Sale, E. J., Bozzetti, L. P., and Will, A. D., Modulation of chemiluminescence in a murine macrophage cell line by neuroendocrine hormones, Int. J. Immunopharm., 15, 615, 1993.
111. Van den Bergh, P., Rozing, J., and Nagelkerken, L., Beta-endorphin stimulates la expression on mouse B cells by inducing interleukin-4 secretion by CD4+ T cells, Cell. Immunol., 149, 180, 1993.
112. Wiedermann, C. J., Schratberger, P., and Kahler, C. M., Migration of neutrophils across endothelial monolayers, Brain Behav. Immunity, 8, 270, 1994.
113. Hagi, K., Inaba, K., Sakuta, H., and Muramatsu, S., Enhancement of murine bone marrow macrophage differentiation by beta-endorphin, Blood, 86, 1316, 1995.
114. Shahabi, N. A. and Sharp, B. M., Antiproliferative effects of delta opioids on highly purified CD4+ and CD8+ murine T cells, J. Pharmacol. Exp. Ther., 273, 1105, 1995.
115. Stefano, G. B., Shipp, M. A., and Scharrer, B., A possible immunoregulatory function for met-enkephalin-Arg6-Phe7 involving human and invertebrate granulocytes, J. Neuroimmunol., 31, 97, 1991.
116. Van Ree, J. M., Bohus, B., Csontos, K. M., Gispen, W. H., Greven, H. M., Nijkamp, F. P., Opmeer, F. A., De Rotte, A. A., Van Wimersma Greidanus, T. J. B., Witter, A., and De Weid, D., Behavioral profile of gamma-MSH: relationship with ACTH and beta-endorphin, Life Sci., 28, 2875, 1981.
117. Smith, E. M., Hughes, T. K. J., Hashemi, F., and Stefano, G. B., Immunosuppressive effects of ACTH and MSH and their possible significance in human immunodeficiency virus infection, Proc. Natl. Acad. Sci. U.S.A., 89, 782, 1992.
118. Tache, Y., Morley, J. E., and Brown, M. R., Neuropeptides and Stress, Springer-Verlag, Berlin, 1989.
119. Duvaux-Miret, O., Stefano, G. B., Smith, E. M., Dissous, C., and Capron, A., Immunosuppression in the definitive and intermediate hosts of the human parasite Schistosoma mansoni by release of immunoactive neuropeptides, Proc. Natl. Acad. Sci. U.S.A., 89, 778, 1992.
120. Pasternak, G. W., Multiple mu opiate receptors: biochemical and pharmacological evidence for multiplicity, Biochem. Pharmacol., 35, 361, 1986.
121. Pasternak, G. W., The Opiate Receptors, Humana Press, New Jersey, 1988.
122. 2 opioid receptors, Proc. Natl. Acad. Sci. U.S.A., 85, 4061, 1988.
123. Clark, J. A., Liu, L., Price, M., Hersh, B., Edelson, M., and Pasternak, G. W., Kappa opiate receptor multiplicity: evidence for two U50, 488-sensitive K1 subtypes and a novel K3 subtype, J. Pharmacol. Exp. Ther., 251, 461, 1989.
124. Rothman, R. B., Bykov, V., DeCosta, B. R., Jacobson, A. E., Rice, K. C., and Brady, L. S., Interaction of endogenous opioid peptides and other drugs with four kappa binding sites in guinea pig brain, Peptides, 11, 311, 1990.
125. Mattia, A., Farmer, S. C., Takemori, A. E., Sultana, M., Portoghese, P. S., Mosberg, H. I., Bowen, W. D., and Porreca, F., Spinal opioid delta antinociception in the mouse mediation by a 5″-NTII-sensitive delta receptor subtype, J. Pharmacol. Exp. Ther., 260, 518, 1992.
126. Stefano, G. B., Paemen, L. R., and Hughes, T. K. J., Autoimmunoregulation: differential modulation of CD10/Neutral endopeptidase 24.11 by tumor necrosis factor and neuropeptides, J. Neuroimmunol., 41, 9, 1992.
127. Traynor, J. R. and Elliott, J., δ-Opioid receptro subtypes and cross-talk with mu-receptors, Trends. Pharmacol. Sci., 14, 84, 1993.
128. Nock, B., Giordano, A. L., Moore, B. W., and Cicero, T. J., Properties of the putative Epsilon opioid receptor in rat, guinea pig, cow, pig and chicken brain, J. Pharmacol. Exp. Ther., 264, 349, 1993.
129. Heyman, J. S., Vaught, J. L., Raffa, R. B., and Porreca, F., Can supraspinal d-opioid receptors mediate antinociception?, Trends. Pharmacol. Sci., 9, 134, 1988.
130. Bodnar, A. and Pasternak, G. W., Neuroregulatory Mechanisms in Aging, Pergamon Press, Oxford, England, 1993.
131. 4] - subsituted derivatives: further evidence of opioid delta receptor multiplicity, J. Pharmacol. Exp. Ther., 265, 896, 1993.
132. Kieffer, B. L., Befort, K., Gavériaux-Ruff, C. E., and Hirth, C. G., The d-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization, Proc. Natl. Acad. Sci. U.S.A., 89, 12048, 1992.
133. Evans, C. J., Keith, D. E. J., Morrison, H., Magendzo, K., and Edwards, R. H., Cloning of a delta opioid receptor by functional expression, Science, 258, 1952, 1992.
134. Chen, Y., Mestek, A., Liu, J., Hurley, J. A., and Yu, L., Molecular cloning and functional expression of a m-opioid receptor from rat brain, Mol. Pharmacol., 44, 8, 1993.
135. Yasuda, K., Raynor, K., Kong, H., Breder, C. D., Takeda, J., Reisine, T., and Bell, G. I., Cloning and functional comparison of k- and d-opioid receptors from mouse brain, Proc. Natl. Acad. Sci. U.S.A., 90, 6736, 1993.
136. Stefano, G. B., Role of opioid neuropeptides in immunoregulation, Prog. Neurobiol., 33, 149, 1989.
137. Makman, M. H., Morphine receptors in immunocytes and neurons, Adv. Neuroimmunol., 4, 69, 1994.
138. 3 receptor in mammalian microglia, astrocytes and kupffer cells, Brain Res., 686, 239, 1995.
139. 3 opiate receptor in endothelial cells: coupling to nitric oxide production and vasodilation, J. Biol. Chem., 270, 30290, 1995.
140. 3 receptors in cultured astrocytes and in brain and retina, Adv. Exp. Med. Biol., 1996.
141. Cruciani, R. A., Dvorkin, B., Morris, S. A., Crain, S. M., and Makman, M. H., Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells, Proc. Natl. Acad. Sci. U.S.A., 90, 3019, 1991.
142. Mendelsohn, L. G., Kerchner, G. A., Culwell, M., and Ades, E. W., Immunoregulation by opioid peptides: I. Absence of classical opioid receptors on human mononuclear cells, J. Clin. Lab. Immunol., 16, 125, 1985.
143. Madden, J. J., Donahoe, R. M., Zwemer-Collins, J., Shafer, D. A., and Falek, A., Binding of naloxone to human T lymphocytes, Biochem. Pharmacol., 36, 4103, 1987.
144. Ovadia, H., Nitsan, P., and Abramsky, O., Characterization of opiate binding sites on membranes of rat lymphocytes, J. Neuroimmunol., 21, 102, 1989.
145. Sharp, B. M., Shahabi, N. A., Peterson, P. K., and Linner, K. M., Biochemical characterization of naloxone-resistant receptors for beta-endorphin on a human mononuclear cell line (U937) and murine splenocytes, Adv. Exp. Biol. Med., 288, 215, 1991.
146. Carr, D. J. J. and Blalock, J. E., Structural and functional similarities of opiate receptors of neural and immune origin, NIDA. Res. Monogr., 96, 122, 1990.
147. Carr, D. J. J., Kim, C. H., DeCosta, B., Jacobson, A. E., Rice, K. C., and Blalock, J. E., Evidence for a delta class opioid receptor on cells of the immune system. Cell. Immunol., 116, 44, 1988.
148. Carr, D. J. J., DeCosta, B., Jacobson, A. E., Rice, K. C., and Blalock, J. E., Anti-opioid receptor antibody recognition of a binding site on brain and leukocyte opioid receptors, Neuroendocrinol., 51, 552, 1990.
149. Carr, D. J. J., DeCosta, B., Jacobson, A. E., Rice, K. C., and Blalock, J. E., Enantioselective kappa opioid binding sites on the macrophage cell line, P388d1, Life Sci., 49, 45, 1991.
150. Radulescu, R. T., DeCosta, B. R., Jacobson, A. E., Rice, K. C., Blalock, J. E., and Carr, D. J. J., Biochemical and functional characterization of a m-opioid receptor binding site on cells of the immune system, Prog. Neuroendocrinimmunol., 4, 166, 1989.
151. Joseph, D. B. and Bidlack, J. M., The k-opioid receptor expressed on the mouse lymphoma cell line R1.1 contains a sulfhydryl group at the active site, Eur. J. Pharmacol., 267, 1, 1994.
152. Joseph, D. B. and Bidlack, J. M., The kappa-opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure, J. Pharmacol. Exp. Ther., 272, 970, 1995.
153. Lawrence, D. P. M., El-Hamouly, W., Archer, S., Leary, J. F., and Bidlack, J. M., Identification of k-opioid receptors in the immune system by indirect immunoflouresence, Proc. Natl. Acad. Sci. U.S.A., 92, 1062, 1995.
154. Heagy, W., Finberg, R., Teng, E., McAllen, K., and Sharp, B., Opiate receptors and signalling in lymphocytes, Adv. Exp. Med. Biol., 1996.
155. Lopker, A., Abood, L. G., Hoss, W., and Lionetti, F. J., Stereoselective muscarinic acetypcholine and opiate receptors in human phagocytic leukocytes, Biochem. Pharmacol., 29, 1361, 1980.
156. Chuang, L. F., Chuang, T. K., Killam, K. F. J., Chuang, A. J., Kung, H. F., Yu, L., and Chuang, R. Y., Delta opiois receptor gene expression in lymphocytes, Biochem. Biophys. Res. Commun., 202, 1291, 1994.
157. Rogers, T. J., Guan, I., Alicea, C., and Belkowski, S. M., Kappa receptor mRNA in cells of the murine immune system, Adv Exp. Med. Biol., 1996.
158. Gavériaux-Ruff, C. E., Simonin, C. F., Peluso, J., Befort, K., and Kieffer, B., Expression of opioid receptor mRNAs in immune cells, Regulatory Peptides, 54, 103, 1994.
159. 3 receptor with selectivity for opiate alkaloids but without affinity for opioid peptides, Brain Res., 667, 229, 1994.
160. 3-opiate receptors, Eur. J. Pharmacol., 273, R5, 1995.
161. Ottavianni, E., Paemen, L. R., Cadet, P., and Stefano, G. B., Evidence for nitric oxide production by invertebrate immunocytes, Eur. J. Pharm. Environ. Toxicol. Pharmacol., 248, 319, 1993.
162. Liu, Y., Casares, F., and Stefano, G. B., d2 opioid receptor mediates immunocyte activation, Chinese J. Neuroimmunol. Neurol., in press, 1996.
163. 3 opiate receptor in invertebrate neural tissues, Comp. Biochem. Physiol., 1996.
164. Lord, J. A. H., Waterfield, A. A., Hughes, J., and Kosterlitz, H. W., Endogenous opioid peptodes: multiple agonists and receptors, Nature, 267, 495, 1977.
165. Gintzler, A. R., Levy, A., and Spector, S., Antibodies as a means of isolating and characterizing biologically active substances: presence of a non-peptide morphine-like compound in the central nervous system, Proc. Natl. Acad. Sci. U.S.A., 73, 2132, 1976.
166. Goldstein, A., Barrett, R. W., James, I. F., Lowney, L. I., Weitz, C., Knipmeyer, L.I., and Rapoport, H., Morphine and other opiates from beef brain and adrenal, Proc. Natl. Acad. Sci. U.S.A., 82, 5203, 1985.
167. Kodaira, H. and Spector, S., Transformation of thebaine to oripavine, codeine, and morphine by rat liver, kidney, and brain microsomes, Proc. Natl. Acad. Sci. U.S.A., 85, 1267, 1988.
168. Bianchi, E., Alessandrini, C., Guarna, M., and Tagliamonte, A., Endogenous codeine and morphine are stored in specific brain neurons, Brain Res., 627, 210, 1993.
169. Cantacuzene, J., Nouvelles recherches sur led mode de destruction des vibrions dans l'organisme, Ann. Inst. Pateur, 12, 274, 1898.
170. Atchard, C., Bernard, H., and Gagneux, C., Action de la morphine sur les proprietes leucocytaires. Leucodiagnostic du morphinisme, Bull. Mem. Soc. Med. Hosp. Paris, 28, 958, 1909.
171. Tubaro, E., Borelli, G., Croce, C., Cavallo, G., and Santiangeli, C., Effect of morphine on resistance to infection, J. Infect. Dis., 148, 656, 1983.
172. Weber, R. J., Band, L. C., DeCosta, B., Pert, A., and Rice, K. C., Neural control of immune function: opioids, opioid receptors and immunosuppression, NIDA Res. Monogr., 105, 96, 1991.
173. Perez-Castrillon, J. P., Perez-Arellano, J. P., Garcia-Palomo, J. D., Jimenez-Lopez, A., and DeCastro, S., Opioids depress in vitro human monocyte
174. Scharrer, B., Paemen, L. R., Smith, E. M., Hughes, T. K. J., Liu, Y., Pope, M., and Stefano, G. B., The presence and effects of mammalian signal molecules in immunocytes of the insect Leucophaea madarae, Cell. Tissue Res., 1996.
175. Malfroy, B., Swerts, J. P., Guyon, A., Roques, B. P., and Schwartz, J. C., High affinity enkephalin degrading peptidase in brain is increased after morphine, Nature, 276, 523, 1978.
176. McDonough, R. J., Madden, J. J., Falek, A., Shafer, D. A., Pline, M., Gordon, D., Bokos, P., Kuehnle, J. C., and Mendelson, J., Alteration of T- and null lymphocyte frequences in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T-lymphocytes, J. Immunol., 125, 2539, 1980.
177. Stefano, G. B., Neuropeptides and Immunoregulation, Springer-Verlag, 1994.
178. Donahoe, R. M., Neuroimmunomodulation by opiates: relationship to HIV-1 infection and AIDS, Adv. Neuroimmunol., 3, 31, 1993.
179. Donahoe, R. M., Bueso-Ramos, C., Donahoe, F., Madden, J. J., and Falek, A., Mechanistic implications of the findings that opiates and other drugs of acuse moderate T-cell surface receptors and antigenic markers, Ann. N.Y. Acad. Sci., 496, 711, 1987.
180. Brummitt, C., Sharp, B., Gekker, G., Keane, W. F., and Peterson, P. K., Progress in Leukocyte Biology, New York, New York, 1987.
181. Peterson, P. K., Sharp, B., Gekker, G., Brummitt, C., and Keane, W. F., Opioid mediated suppression of interferon-y production by cultured peripheral blood mononuclear cells, J. Clin. Invest., 80, 824, 1987.
182. Peterson, P. K., Sharp, B., Gekker, G., Brummitt, C., and Keane, W. F., Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity, J. Immunol., 138, 3907, 1987.
183. Eisenberg, R. M., Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists, J. Pharmacol. Exp. Ther., 233, 863, 1985.
184. Nikolarakis, K. E., Pfeiffer, A., Stalla, G., and Herz, A., The role of CRF in the release of ACTH by opiate agonists and antagonists in rats, Brain Res., 421, 373, 1987.
185. Nikolarakis, K. E., Pfeiffer, A., Stalla, G., and Herz, A., Facilitation of ACTH secretion by morphine is mediated by activation of CRF releasing neurons and sympathetic neuronal pathways. Brain Res., 498, 385, 1989.
186. Bryant, H. U., Yoburn, B. B., Inturrisi, C. E., Bernton, E. W., and Holaday, J. W., Morphine-induced immunosuppression is not related to serum morphine concentrations, Eur. J. Pharmacol., 149, 165, 1988.
187. Bayer, B. M. and Flores, C. M., Drugs Abuse Immune Function, CRC Press, Boca Raton, Florida, 1990.
188. Stefano, G. B., Invertebrate and vertebrate immune and nervous system signal molecule commonalities, Cell. Mol. Neurobiol., 12, 357, 1992.
189. Magazine, H. I., Liu, Y., Bilfinger, T. V., Fricchione, G. L., and Stefano, G. B., Morphine-induced conformational changes in immunocytes, endothelial cells and microglia are mediated by nitric oxide, J. Immunol., 156, 4845, 1996.
190. Howard, M., O'Garra, A., Ishida, H., de Waal Malefy, T. R., and De Vries, J., Biological properties of interleukin 10, J. Clin. Immunol., 12, 239, 1992.
191. Moore, K. W., O'Garra, A., de Waal Malefy, T. R., Viera, P., and Mosmann, T. R., Interleukin 10, Ann. Rev. Immunol., 11, 165, 1993.
192. Stefano, G. B., Rodriquez, M., Glass, R., Casares, F., Hughes, T. K. J., and Bilfinger, T. V., Hyperstimulation of leukocytes by plasma obtained from cardiopulmonary bypass patients is diminished by morphine and IL-10 pretreatment, J. Cardiovasc. Surg., 36, 25, 1995.
193. Stefano, G. B., Cadet, P., Dokun, A., and Scharrer, B., A neuroimmunoregulatory-like mechanism responding to electrical shoack in the marine bivalve Mytilus edulis, Brain Behav. Immunity, 4, 323, 1991.
194. Donnerer, J., Cardinale, G., Coffey, J., Lisek, C. A., Jardine, I., and Spector, S., Chemical characterization and regulation of endogenous morphine and codeine in the rat, J. Pharmacol. Exp. Ther., 242, 583, 1987.
195. Lee, C. S. and Spector, S., Changes of endogenous morphine and codeine contents in fasting rat, J. Pharmacol Exp. Ther., 257, 647, 1991.
196. Fricchione, G. L., Mendoza, A., and Stefano, G. B., Morphine and its psychiatric implications, Adv. Neuroimmunol., 4, 117, 1994.
197. Thomas, P. T., Bhargava, H. N., and House, R. V., Immunomodulatory effects of in vitro exposure to morphine and its metabolites, Pharmacology, 50, 51, 1995.
198. Thomas, P. T., House, R. V., and Bhargava, H. N., Direct cellular immunomodulation produced by diacetylmorphine (heroine) or methadone, Gen. Pharmacol., 26, 123, 1995.
199. Bhargava, H. N., Thomas, P. T., Thorat, S. N., and House, R. V., Effects of morphine tolerance and abstinence on cellular immune function, Brain Res., 642, 1, 1994.
200. LeVier, D. G., McCay, J. A., Stern, M. L., Harris, L. S., Page, D., Brown, R. D., Musgrove, D. L., Butter-worth, L. F., White, K. L., and Munson, A. E., Immunotoxicological profile of morphine sulfate in B6C3F1 mice, Fundam. Appl. Toxicol., 22, 525, 1994.
201. Singh, V. K., Jakubovic, A., and Thomas, D. A., Suppressive effects of methadone on human blood lymphocytes, Immunol. Lett., 53, 269, 1980.
202. Peterson, P. K., Gekker, G., Brummitt, C., Pentel, P., Bullock, M., Simpson, M., Hitt, J., and Sharp, B., Suppression of human peripheral blood mononuclear cell function by methadone and morphine, J. Infect. Dis., 159, 480, 1989.
203. Kreek, M. J., Immunological function in active heroin addicts and methadone-maintained former addicts: observations and possible mechanisms, NIDA Res. Monogr., 105, 75, 1991.
204. Shavit, Y., Martin, F. C., Yirmiya, R., Ben-Eliyahu, S., Terman, G.W., Weiner, H., Gale, R. P., and Liebeskind, J. C., Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity, Brain Behav. Immunity, 1, 318, 1987.
205. Bayer, B. M., Close, K., Hernandez, M., and Irvin, L., Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism, Immunopharmacology, 29, 369, 1990.
206. House, R. V., Thomas, P. T., and Bhargava, H. N., In vitro evaluation of fentanyl and meperidine for immunomodulatory activity, Immunol. Lett., 46, 117, 1995.
207. Bilfinger, T. V. and Kushnerik, V., The use of morphine in surgery: an overview, Adv. Neuroimmunol., 4, 133, 1994.
208. Lowenstein, E., Hallowell, P., and Levine, F. H., Cardiovascular response to large doses of intravenous morphine in man, N. Engl. J. Med., 281, 1389, 1969.
209. Walsh, E. S., Paterson, J. L., O'Riordan, J. B. A., and Hall, G. M., Effect of high dose fentanyl anesthesia on the metabolic and endocrine response to cardiac surgery, Br. J. Anesth., 53, 1155, 1981.
210. DeLange, S., Boscoe, H. J., Stanley, T. H., de Bruijin, N., Philbin, D. M., and Coggins, C. H., Antidiuretic and growth hormone responses during coronary artery surgery with oxygen and sufentanil oxygen anesthesia in man, Anesth. Analg., 61, 434, 1982.
211. Bovill, J. G., Sebel, P. S., Fiolet, J. W. T., Touber, J. L., Kok, K., and Philbin, D. M., The influence of sufentanil on endocrine and metabolic response to cardiac surgery, Anesth. Analg., 62, 391, 1983.
212. Tonnesen, E., Brinklov, H. H., Christensen, N. J., Olesen, A. S., and Madsen, T., Natural killer cell activity and lymphocyte formation during and after coronary artery bypass grafting in relation to the endocrine stress response, Anesthesiology, 67, 526, 1987.
213. George, J. M., Reies, C. E., Lanese, R. R., and Rower, J. M., Morphine anesthesia blocks cortisol and growth hormone response to surgical stress in humans, J. Clin. Endocrinol. Metab., 38, 736, 1975.
214. Bent, J. M., Paterson, J. L., Mashiter, K., and Hall, J. M., Effects of high-dose fentanyl anesthesia on the established metabolic and endocrine response to surgery, Anesthesiology, 39, 19, 1984.
215. Bryant, H. U., Berulaon, E. W., Kenner, J. R., Shakarjian, T. K., and Holaday, J. W., Suppression of macrophage function and increased lethal bacterial infection in mice given morphine pellet implants, FASEB. J., 2, A1260, 1988.
216. Anand, K. J., Sippell, W. G., and Green, A., Randomized trial fentanyl anesthesia in preterm neonates undergoing surgery: effects on the stress response, Lancet, 1, 62, 1987.
217. Cooper, G. M., Paterson, J. L., Ward, I. D., and Hall, G. M., Fentanyl and the metbolic response to gastric surgery, Anesthesia, 31, 667, 1981.
218. Anand, K. J. and Hickey, P. R., Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery, N. Engl. J. Med., 326, 1, 1992.
219. Anand, K. J. and Hickey, P. R., Pain and its effects in the human neonate and fetus, N. Engl. J. Med., 317, 1321, 1987.
220. Yeager, M. P., Glass, D. D., Neff, R. K., and Brink-Johnson, T., Epidural anesthesia and analgesia in high-risk surgical patients, Anesthesiology, 66, 729, 1987.
221. Roizen, M. F., Lampe, G. H., and Benfiel, D. J., Is increased operative stress associated with worth the outcome, Anesthesiology, 6, A1, 1987.
222. Scott, N. B. and Kehlet H., Regional anesthesia and surgical morbidity, Br. J. Surg., 75, 299, 1988.
223. Carr, D. J. J., DeCosta, B., Kim, C. H., Jacobson, A. E., Rice, K. C., Carr, D. B., Balentine, J. C., Osgood, P. F., Kemp, J. W., and Szyfelbein, S. K., Pituitary adrenal stress response in the absence of brain pituitary connections, Anesth. Analg., 69, 197, 1989.
224. Bilfinger, T. V., Complement activation during extracorporeal circulation, Adv. Neuroimmunol., 3, 269, 1993.
225. Bilfinger, T. V. and Stefano, G. B., Evidence of immunocyte stimulatory molecule(s) in plasma of patients undergoing cardiopulmonary bypass, J. Cardiovasc. Surg., 34, 129, 1993.
226. Bilfinger, T. V., Fricchione, G. L., and Stefano, G. B., Neuroimmune implications of cardiopulmonary bypass, Adv. Neuroimmunol., 3, 277, 1993.
227. Stefano, G. B., Bilfinger, T. V., and Fricchione, G. L., The immune-neuro link and the macrophage: postcardiotomy delirium, HIV-associated dementia and psychiatry, Prog. Neurabiol., 42, 475, 1994.
228. Buckner, C. and Clift R., Prophylaxis and treatment of infection of the immunocompromised host by granulocyte transfusion, Clin. Hematol., 13, 557, 1984.
229. Eckenhoff, J. E. and Oech, S. R., The effects of narcotics and antagonists upon respiration and circulation in men, Clin. Pharmacol. Ther., 1, 483, 1961.
230. Zelis, R., Flaim, S. F., and Eisele, J. H., Effects of morphine on reflex arteriolar constriction induced in man by hypercapnia, Clin. Pharmacol. Ther., 22, 172, 1977.
231. Lee, G., DeMaria, A., Amstredam, E. A., Realy-Vasquez, E., Angel, J., Morrison, S., and Mason, D. T., Comparative effects of morphine, meperidine, and pentazocine and cardiocirculatory dynamics in patients with acute myocardial infarction, Am. J. Med., 60, 949, 1976.
232. Vismara, L. A., Leamon, D. M., and Zelis, R., The effects of morphine on venous tone in patients with acute pulmonary edema, Circulation, 54, 335, 1976.
233. Jaffe, J. H. and Martin, W. R., Opioid Analgesics and Antagonists in the Pharmacological Basis of Therapeutics, Pergamon Press, New York, 1990.
234. Bilfinger, T. V., Hartman, A., Liu, Y., Magazine, H. I., and Stefano, G. B., Morphine stimulates in vitro nitric oxide production in human blood vessels inhibiting the adherence of granulocytes and monocytes: this activity is not present in cryopreserved vessels, in review, 1996.
235. Kubes, P., Suzuki, M. M., and Granger, D. N., Nitric oxide an endogenous modulator of leukocyte adhesion, Proc. Natl. Acad. Sci. U.S.A., 88, 4651, 1991.
236. Kurose, I., Kubes, P., and Wolf, R., Inhibition of nitric oxide production: mechanisms of vascular albumin leakage, Circ. Res., 73, 164, 1993.
237. Kubes, P. and Granger, D. N., Nitric oxide modulates microvascular permeability, Am. J. Physiol., 262, H611, 1992.
238. Kurose, I., Wolf, R., and Granger, D. N., Dimethyl-L-arginine, an endogenous inhibitor of nitric oxide (NO) synthesis, elicits an inflammatory response in the rat mesenteric microcirculation, Gastroenterology, 106, A245, 1994.
239. Kubes, P., Kanwar, S., and Niu, X. F., Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells, FASEB. J., 7, 1293, 1993.
240. Suematsu, M., Tamatani, T., and Delano, F. A., Microvascular oxidative stress preceding leukocyte activation elicited by in vivo nitric oxide suppression, Am. J. Physiol., 266, H2410, 1994.
241. Ma, X. L., Weyrich, A. S., and Leter, D. J., Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium, Circ. Res., 72, 403, 1993.
242. Radomski, M. W., Plamer, R. M. J., and Moncada, S., Endogenous nitric oxide inhibits hu-man platelet adhesion to vascular endothelium, Lan-cet, 2, 1057, 1987.
243. Simon, D. I., Stamler, J. S., and Jaraki, O., Antiplatelet properties of protein 5-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor, Arterioscler. Thromb., 13, 791, 1993.
244. Bath, P. M. W., Hasall, D. G., and Gladwin, A. M., Palmer, R. M., and Martin, J. F., Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro, Arterioscler. Thromb., 11, 254, 1991.
245. Peterson, P. K., Sharp, B., Gekker, G., Portoghese, P. S., Sannerud, K., and Balfour, H. H., Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures, AIDS, 4P, 869, 1990.
246. Peterson, P. K., Gekker, G., Hu, S., Anderson, W. R., Kravitz, F., Portoghese, P. S., Balfour, H. H., and Chao, C. C., Morphine amplifies HIV-1 expression in chronically infected promonocytes co-cultured with human brain cells, J. Neuroimmunol., 50, 167, 1994.
247. Chao, C. C., Gekker, G., Hu, S., Sheng, W. S., Portoghese, P. S., and Peterson, P. K., Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin, Biochem. Pharmacol., 1995.
248. Chao, C. C., Gekker, G., Sheng, W. S., Hu, S., Portoghese, P. S., and Peterson, P. K., Endogenous opioid peptides suppress cytokine-mediated upregulation of HIV-1 expression in the chronically infected promonocyte clone U1, Adv. Exp. Med. Biol., 373, 65, 1995.
249. Peterson, P. K., Gekker, G., Hu, S., Sheng, W. S., Molitor, T. W., and Chao, C. C., Morphine stimulates phagocytosis of Mycobacterium tuberculosis by human microglial cells: involvement of a G protein-coupled opiate receptor, Adv. Neuroimmunol., 5, 299, 1995.
250. Risdahl, J. M., Peterson, P. K., Chao, C. C., Pijoan, C., and Molitor, T. W., Effects of morphine on the pathogenesis of swine herpesvirus infection, J. Infect. Dis., 167, 1281, 1993.
251. Stefano, G. B., Scharrer, B., and Fricchione, G. L., Endogenous morphine and the physiological significance of tolerance in amplification brain phenomena, Adv. Neuroimmunol., in press, 1996.
252. Duvaux-Miret, O., Dissous, C., Guatron, J. P., Pattou, E., Kordon, C., and Capron, A., The helminth Schistosoma mansoni expresses a peptide similar to human beta-endorphin and possesses a POMC-related gene, New Biol., 2, 93, 1990.
253. Duvaux-Miret, O., Leung, M. K., Capron, A., and Stefano, G. B., An enkephalinergic system in Schistosoma mansoni that may participate in intra- and extraorganismic signaling, Exp. Parasit., 76, 76, 1993.
254. Leung, M. K., Dissous, C., Capron, A., Woldegaber, H., Duvaux-Miret, O., Pryor, S., and Stefano, G. B., Schlstosoma mansoni: the presence and potential use of opiate-like substances, Exp. Parasit., 81, 208, 1995.
255. Stefano, G. B., Comparative Opioid and Related Neuropeptides Mechanisms, CRC Press, Boca Raton, Florida, 1986.
256. Stefano, G. B., The evolvement of signal systems: conformational matching a determining force stabilizing families of signal molecules, Comp. Biochem. Physiol., 90, 287, 1988.
257. Stefano, G. B., Conformational matching a stabilizing signal system factor during evolution: additional evidence in comparative neuroimmunology, Adv. Neuroimmunol., 1, 71, 1991.
258. Stefano, G. B. and Smith, E. M., Adrenocorticotropin, a central trigger in immune responsiveness: tonal inhibition of immune activation, Med. Hypothesis, 46, 471, 1996.